INTERNATIONAL PATENT: NATIONAL CANCER CENTER, 국립암센터 FILES APPLICATION FOR "NOVEL ANTIBODY SPECIFICALLY BINDING TO GPC3 AND USE THEREOF"

GENEVA, Aug. 5 -- NATIONAL CANCER CENTER (323 Ilsan-ro, Ilsandong-guGoyang-siGyeonggi-do 10408), 국립암센터 (경기도고양시일산동구 일산로 323) filed a patent application (PCT/KR2025/001458) for "NOVEL ANTIBODY SPECIFICALLY BINDING TO GPC3 AND USE THEREOF" on Jan 24, 2025. With publication no. WO/2025/159562, the details related to the patent application was published on Jul 31, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HAN, Chung Yong (1801-1503, 100 Convensia-daero 130beon-gilYeo...